The drugs help manage blood sugar and promote weight loss, they come with likely side effects
Key Takeaways: GLP-1 vs GIP Both are incretin hormones released by your intestines after eating GLP-1 primarily affects appetite, gastric emptying, and insulin secretion GIP influences insulin secretion, glucagon regulation, and fat metabolism Single GLP-1 agonists (semaglutide) produce 14.9% average weight loss Dual GLP-1/GIP agonists (tirzepatide) produce 22.5% average weight loss The dual action appears to create additive rather than merely overlapping effects Both receptor types play important roles in metabolic regulation Understanding the difference helps explain why tirzepatide shows superior results What Are Incretin Hormones
According to a recent survey conducted by the San Francisco-based healthcare consultancy Omada Health, those concerns are growing as telehealth services play an increasing role in prescribing these medications, often without the involvement of the patients primary care physician
Many Medicare enrollees can get GLP-1 drugs for $50 starting in July "There's so much information spreading about everything related to GLP-1s right now," Saunders explained
This dominance reflects the current treatment paradigm where GLP-1 medications are primarily positioned and reimbursed for obesity management based on BMI criteria rather than cardiovascular risk reduction